Shamburg News · 8-K filed Nov 9, 2026, 7:20 AM EST
Tonix Pharmaceuticals Reports Operating Results for Quarter Ended September 30, 2026
TNXP · Tonix Pharmaceuticals Holding Corp.
- Earnings
- Materiality: medium
On November 9, 2026, Tonix Pharmaceuticals Holding Corp. announced its operating results for the quarter ended September 30, 2026. The results are described in a press release filed as Exhibit 99.01 to the report, which is incorporated by reference. The filing itself does not state specific revenue, net income, or per-share figures in the text provided.
Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001493152-26-050621.
Written from the filing by Shamburg Markets. Figures are as reported by the company.